Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-044152
Filing Date
2024-05-16
Accepted
2024-05-16 12:56:14
Documents
16
Period of Report
2023-12-01
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0205857-8ka1_china.htm   iXBRL 8-K/A 31345
2 UNAUDITED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2023 AND ea020585701ex99-1_china.htm EX-99.1 149460
3 AUDITED FINANCIAL STATEMENTS FOR THE FISCAL YEARS ENDED JUNE 30, 2023 AND 2022 O ea020585701ex99-2_china.htm EX-99.2 153078
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS AS OF AND FOR THE TH ea020585701ex99-3_china.htm EX-99.3 143194
  Complete submission text file 0001213900-24-044152.txt   710875

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE chhe-20231201.xsd EX-101.SCH 3054
6 XBRL LABEL FILE chhe-20231201_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE chhe-20231201_pre.xml EX-101.PRE 22385
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0205857-8ka1_china_htm.xml XML 4611
Mailing Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028
Business Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028 011-86-451-51719407
China Health Industries Holdings, Inc. (Filer) CIK: 0001309057 (see all company filings)

EIN.: 860827216 | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 000-51060 | Film No.: 24954353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)